| Literature DB >> 34930627 |
Asha Daryanani1, Baris Turkbey2.
Abstract
CT and MRI are both commonly used in prostate cancer (PCa) management, which includes a large spectrum from screening positive pre-diagnosis phase to metastatic disease. CT and MRI have continually evolved to meet the changing demands for PCa management. For CT, novel techniques such as dual energy CT and photon counting CT show promising results for tissue characterization and quantification. For MRI, the detection, staging, and management of prostate cancer has been significantly improved by the development of multiparametric, biparametric, and whole-body MRI techniques. Additionally, research on ultrasmall superparamagnetic particles of iron oxide contrast-enhanced MRI has revealed promising results for nodal staging of PCa. In this manuscript we aim to outline the current status and recent advancements of CT and MRI in PCa imaging.Entities:
Mesh:
Year: 2021 PMID: 34930627 PMCID: PMC9038642 DOI: 10.1053/j.semnuclmed.2021.11.013
Source DB: PubMed Journal: Semin Nucl Med ISSN: 0001-2998 Impact factor: 4.802